A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
Clinical trial NCT04629209 · WITHDRAWN
Trial details
- NCT number
- NCT04629209
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2024-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.